P2.03-044 OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC

Authors :: Nick Pavlakis
Peey-Sei Kok
Ben Solomon
Stephen Q. Wong
Martin R. Stockler
Sarah-Jane Dawson
Sonia Yip
Christopher L. Brown
Ann Livingstone
Source :: Journal of Thoracic Oncology. 12:S2144
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
EGFR T790M
T790M
Gefitinib
Internal medicine
Mutation (genetic algorithm)
medicine
Physical therapy
In patient
Osimertinib
business
medicine.drug

Tools